NEW YORK (Reuters Health) – An investigational phosphodiesterase type 5 (PDE5) inhibitor, avanafil, is an effective and well tolerated treatment for erectile dysfunction (ED), according to the results…
NEW YORK (Reuters Health) – Most prostate cancers detected after more than two biopsies turn out to be clinically insignificant, according to a report from the Cleveland Clinic,…
NEW YORK (Reuters Health) – The addition of bevacizumab (Avastin; Genentech/Roche) to the standard docetaxel and prednisone in men with progressive metastatic castration-resistant prostate cancer (mCRPC) did not…
NEW YORK (Reuters Health) – Women with a history of nephrolithiasis have higher fractional calcium absorption, but consuming adequate calcium reduces fractional absorption and may help prevent kidney…
NEW YORK (Reuters Health) – A cause of visible hematuria can be determined in almost half of cases, according to a report from Aberdeen Royal Infirmary in Scotland,…
NEW YORK (Reuters Health) – Varicocelectomy leads to significant improvements in sperm count and motility, regardless of surgical technique (i.e., high ligation, inguinal or subinguinal approach), a meta-analytic…
NEW YORK (Reuters Health) – Pain associated with acute renal colic is relieved more effectively when intravenous papaverine is added to treatment with diclofenac suppository, an Iranian team…
NEW YORK (Reuters Health) – Antibiotic prophylaxis based on rectal swab cultures in men undergoing transrectal ultrasound-guided prostate biopsies (TRUSP) reduces the incidence of post-procedure infectious complications. Furthermore,…
NEW YORK (Reuters Health) – Avanafil, another phosphodiesterase type 5 (PDE5) inhibitor, improves sexual function in men with erectile dysfunction, according to a report in the January 16th…
NEW YORK (Reuters Health) – Men 60 years old and younger have excellent quality-of-life outcomes after proton therapy for prostate cancer, according to findings published in the January…